Zobrazeno 1 - 10
of 142
pro vyhledávání: '"R. R. Tubbs"'
Autor:
D P S, Sohal, T W, Rice, L A, Rybicki, C P, Rodriguez, G M M, Videtic, J P, Saxton, S C, Murthy, D P, Mason, B E, Phillips, R R, Tubbs, T, Plesec, M J, McNamara, D I, Ives, J W, Bodmann, D J, Adelstein
Publikováno v:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 28(6)
The role of epidermal growth factor receptor inhibition in resectable esophageal/gastroesophageal junction (E/GEJ) cancer is uncertain. Results from two Cleveland Clinic trials of concurrent chemoradiotherapy (CCRT) and surgery are updated and retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6662ecf90af655bc69f85d9075af326b
https://pubmed.ncbi.nlm.nih.gov/24849395
https://pubmed.ncbi.nlm.nih.gov/24849395
Publikováno v:
Molecular Pathology. 54:259-263
Background/Aims—It was recently reported that significantly fewer breast tumours of BRCA1 mutation carriers overexpressed cyclin D1 and HER2 protein than tumours of age matched breast cancer cases unselected for family history. This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ca1559db7ffbe80161a2e9edadbca3
https://doi.org/10.1136/mp.54.4.259
https://doi.org/10.1136/mp.54.4.259
Autor:
R. R. Tubbs, Thomas M. Grogan, Robert B. Jenkins, Patrick C. Roche, J. Pettay, Mark H. Stoler
Publikováno v:
Journal of Clinical Oncology. 19:2714-2721
BACKGROUND: Several studies have reported what seem to be false-positive results using the Food and Drug Administration (FDA)–approved HercepTest (Dako Corp, Carpinteria, CA) to profile Her-2/neu amplification and overproduction in breast carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf483fb319ef124e0c1ea1be70664881
https://doi.org/10.1200/jco.2001.19.10.2714
https://doi.org/10.1200/jco.2001.19.10.2714
Publikováno v:
Histopathology. 33:501-507
Aims: Poorly differentiated synovial sarcoma (PDSS) is a round cell sarcoma that may be difficult to distinguish from other round cell sarcomas, such as peripheral primitive neuroectodermal tumour (pPNET), on histological examination alone. Furthermo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed8a0f74e666006c1620d3adacbf4e01
https://doi.org/10.1046/j.1365-2559.1998.00562.x
https://doi.org/10.1046/j.1365-2559.1998.00562.x
Autor:
B E, Phillips, R R, Tubbs, T W, Rice, L A, Rybicki, T, Plesec, C P, Rodriguez, G M, Videtic, J P, Saxton, D I, Ives, D J, Adelstein
Publikováno v:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 26(3)
Human epidermal growth factor receptor 2 (HER2) is overexpressed in 21% of gastric and 33% of gastroesophageal junction (GEJ) adenocarcinomas. Trastuzumab has been approved for metastatic HER2-positive gastric/GEJ cancer in combination with chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52b4a25ae3b4fde2ed2b51fe63ff5cf2
https://pubmed.ncbi.nlm.nih.gov/22676551
https://pubmed.ncbi.nlm.nih.gov/22676551
Publikováno v:
Leukemia & Lymphoma. 9:91-94
TIA-1 is a monoclonal antibody (mAb) that identifies cytolytic cells. We studied eleven B cell non-Hodgkin's lymphomas (NHL) of low grade, eleven B cell NHL of intermediate-high grade, and 10 benign lymphoid hyperplasias (BLH) to investigate potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae40866e1dd7612bb87c853856c6dd9e
https://doi.org/10.3109/10428199309148509
https://doi.org/10.3109/10428199309148509
Publikováno v:
Histopathology. 21:563-567
Monoclonal antibody anti-Leu19, is a marker of natural killer cells. Since reactivity between anti-Leu7, another natural killer cell marker, and small cell neuroendocrine carcinomas has been described, we evaluated the reactivity of anti-Leu19 in 92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ac0597aa6a663a55248eb0462d9617
https://doi.org/10.1111/j.1365-2559.1992.tb00445.x
https://doi.org/10.1111/j.1365-2559.1992.tb00445.x
Publikováno v:
Leukemia & Lymphoma. 8:477-481
Monoclonal antibodies (mAb) reactive with seven distinct T cell receptor (TcR) α/β variable region (V) families have become available. We investigated the potential utility of these mAb to establish T cell clonality (restrictive expression of one s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4fd4e712d5afe8d6b40ebda2e34c7f1
https://doi.org/10.3109/10428199209051030
https://doi.org/10.3109/10428199209051030
Publikováno v:
Analytical and quantitative cytology and histology. 23(6)
To evaluate the feasibility of performing multicolor interphase fluorescence in situ hybridization (FISH) on ThinPrep slides of transitional cell carcinoma (TCC).Slides from 20 voided urine specimens were prepared by the ThinPrep technique (Cytyc, Bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f14f5a8e13fb5e9160e3762708084aae
https://pubmed.ncbi.nlm.nih.gov/11777271
https://pubmed.ncbi.nlm.nih.gov/11777271
Autor:
S A, Vaziri, L M, Krumroy, P, Elson, G T, Budd, G, Darlington, J, Myles, R R, Tubbs, G, Casey
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(7)
Breast tumors of BRCA1 mutation carriers and those of early onset breast cancer cases share similar histological features, being generally high-grade, highly proliferative, aneuploid tumors that are predominantly estrogen- and progesterone-receptor n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7faab4d98c6eb377117839904f2e5cee
https://pubmed.ncbi.nlm.nih.gov/11448907
https://pubmed.ncbi.nlm.nih.gov/11448907